Company intelligence / Profile preview
Double Bond Pharmaceutical
Uppsala, Swedendoublebp.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Double Bond Pharmaceutical focuses on innovative drug formulations and targeted drug delivery systems to improve efficacy and safety in treating brain cancer, liver cancer, pneumonia, and lung cancer. Its lead asset SI‑053—a locally administered temozolomide gel for glioblastoma—has entered Phase I clinical trials in the Netherlands and Germany. The company also develops Belopenem for pneumonia using its BeloGal® platform to deliver antibiotics directly to infected lungs. Preclinical programs include candidates targeting lung and liver cancers. Early results from a prototype of SI‑053 showed a significant survival benefit over standard care in glioblastoma patients.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small molecules (e.g., temozolomide gel SI-053)Drug delivery systems (localized delivery platforms)Antibiotics (e.g., meropenem formulation Belopenem)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Vivo Biopharma LLC—collaboration on Temodex/SI–053 asset purchase & development
Beyond the preview
Go deeper on Double Bond Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Double Bond Pharmaceutical.